Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (401-410 of 1,126) with videos related to

Pageof 113
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree modelJean-Simon Diallo, Abdulhadi Aldejmah, Abdelali Filali Mouhim, et al.
European Journal of Cancer (Oxford, England : 1990)|April 12, 2026
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trialBertrand Tombal, Maha Hussain, Fred Saad, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2018
The effect of race on survival after local therapy in metastatic prostate cancer patientsElio Mazzone, Marco Bandini, Felix Preisser, et al.
The Canadian Journal of Urology|October 4, 2018
Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional databaseDaniel Taussky, Felix Preisser, Pierre I Karakiewicz, et al.
Urologic Oncology|May 20, 2019
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based studySophie Knipper, Felix Preisser, Elio Mazzone, et al.
European Urology|October 6, 2018
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate CancerLorenzo Tosco, Alberto Briganti, Antony Vincent D'amico, et al.
World Journal of Urology|April 1, 2015
BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS)Katharina Boehm, Roger Valdivieso, Malek Meskawi, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancerSoumyajit Roy, Yilun Sun, Cristopher J D Wallis, et al.
Human Pathology|April 12, 2024
Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in CanadaMichel Wissing, Fadi Brimo, Ginette McKercher, et al.
European Urology|April 3, 2024
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Gagan Fervaha, Daniel E Spratt, et al.
Pageof 113

Showing results (401-410 of 1,126) with videos related to

Sort By:
Pageof 113
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree modelJean-Simon Diallo, Abdulhadi Aldejmah, Abdelali Filali Mouhim, et al.
European Journal of Cancer (Oxford, England : 1990)|April 12, 2026
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trialBertrand Tombal, Maha Hussain, Fred Saad, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2018
The effect of race on survival after local therapy in metastatic prostate cancer patientsElio Mazzone, Marco Bandini, Felix Preisser, et al.
The Canadian Journal of Urology|October 4, 2018
Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional databaseDaniel Taussky, Felix Preisser, Pierre I Karakiewicz, et al.
Urologic Oncology|May 20, 2019
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based studySophie Knipper, Felix Preisser, Elio Mazzone, et al.
European Urology|October 6, 2018
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate CancerLorenzo Tosco, Alberto Briganti, Antony Vincent D'amico, et al.
World Journal of Urology|April 1, 2015
BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS)Katharina Boehm, Roger Valdivieso, Malek Meskawi, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancerSoumyajit Roy, Yilun Sun, Cristopher J D Wallis, et al.
Human Pathology|April 12, 2024
Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in CanadaMichel Wissing, Fadi Brimo, Ginette McKercher, et al.
European Urology|April 3, 2024
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Gagan Fervaha, Daniel E Spratt, et al.
Pageof 113